Sarepta Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 11.97%146.700.0%$2591.12m
BNGOBioNano Genomics, Inc. 27.14%12.460.0%$2563.79m
GILDGilead Sciences, Inc. 1.75%68.111.0%$661.07m
AMGNAmgen, Inc. 1.26%256.701.3%$571.72m
REGNRegeneron Pharmaceuticals, Inc. 1.86%547.762.7%$486.96m
ALXNAlexion Pharmaceuticals, Inc. 0.95%161.242.0%$475.03m
CRSPCRISPR Therapeutics AG -3.69%181.540.6%$470.00m
NVAXNovavax, Inc. 3.17%131.0092.9%$430.65m
ILMNIllumina, Inc. 3.57%420.753.5%$410.88m
VRTXVertex Pharmaceuticals, Inc. 1.81%241.891.9%$368.40m
SRPTSarepta Therapeutics, Inc. -2.07%96.2013.8%$357.22m
BIIBBiogen, Inc. 2.05%274.961.7%$328.49m
BNTXBioNTech SE 1.58%110.150.0%$303.04m
EXASEXACT Sciences Corp. 2.42%153.6319.6%$249.86m
PACBPacific Biosciences of California, Inc. -3.85%35.987.4%$219.39m

Company Profile

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.